Vifor Pharma and Travere Therapeutics announce licensing agreement for the commercialization of sparsentan in Europe, Australia and New Zealand
ST. GALLEN, Switzerland & SAN DIEGO, Calif. -- (BUSINESS WIRE) -- Regulatory News: This press release features multimedia. View the full release here: https://www.businesswire.com/new......
